诺唯赞:股东国寿成达拟减持不超3%公司股份
Summary of Key Points - The core point of the article is that Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), a shareholder of NuoVas, plans to reduce its stake in the company due to its own funding needs [1] Group 1 - Guoshou Chengda holds 30.958 million shares of NuoVas, accounting for 7.78% of the total shares [1] - The planned reduction includes a maximum of 7.9547 million shares through block trading and 3.9773 million shares through centralized bidding, totaling up to 11.932 million shares, which is no more than 3% of the company's total share capital [1] - All shares to be reduced were acquired before the IPO [1]
